US4387160A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Immunochemical assay for creatine kinase-MB isoenzyme
Assignee: Roche Diabetes Care Inc
•
Filing: 1981-02-17
•
Granted: 1983-06-07
•
Expires: 2001-02-17
Abstract
Abstract An immunochemical process and test kit for determining accurately the amount of creatine kinase-MB isoenzyme (CK-MB) in biological fluids employing two separate immunoassays to a single sample of the biological fluid. This process and test kit are useful in diagnosing myocardial infarct.
Inventors
- 👤 Magdalena U. Gomez
- 👤 Marvin L. Miller
- 👤 Richard W. Wicks
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 10:57
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/573; Y; Y10; Y10S; Y10S435/00; Y10S435/971
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
241 words
A process for quantitatively determining in a biological fluid sample the presence of creatine kinase-MB isoenzyme where the creatine kinase can occur in biological fluids in a plurality of isoenzyme forms containing the subunit M or B or both, the process comprising: a. incubating in a first reaction vessel a first of two portions of the biological fluid sample with a first antibody which selectively binds immunologically with the creatine kinase isoenzymes containing the M subunit by selective immunoinhibition of the M subunit in the first portion of the sample and thereafter quantitatively measuring the B isoenzyme activity of the first portion of the sample, b. incubating in a separate reaction vessel the second of two portions of the biological fluid sample with: (i) an antibody which selectively binds immunologically with the creatine kinase isoenzymes containing the M subunit in the second portion sample; and (ii) a second antibody which selectively binds immunologically to form a solid phase with the antibody binding the creatine kinase isoenzymes containing the M subunit, to produce as a precipitate the reaction product of said second antibody with said other antibody and said creatine kinase isoenzymes containing the M subunit and thereafter quantitatively measuring the B isoenzyme activity of the supernatant in said second portion; and c. determining the CK-MB activity in said sample from said measurements through the substraction of the measurement obtained in the second portion, from the measurement obtained in the first portion.
Claim 2
Dependent Claim
241 words
A process for quantitatively determining in a biological fluid sample the presence of creatine kinase-MB isoenzyme where the creatine kinase can occur in biological fluids in a plurality of isoenzyme forms containing the subunit M or B or both, the process comprising: a. incubating in a first reaction vessel a first of two portions of the biological fluid sample with a first antibody which selectively binds immunologically with the creatine kinase isoenzymes containing the M subunit by selective immunoinhibition of the M subunit in the first portion of the sample and thereafter quantitatively measuring the B isoenzyme activity of the first portion of the sample, b. incubating in a separate reaction vessel the second of two portions of the biological fluid sample with: (i) an antibody which selectively binds immunologically with the creatine kinase isoenzymes containing the M subunit in the second portion sample; and (ii) a second antibody which selectively binds immunologically to form a solid phase with the antibody binding the creatine kinase isoenzymes containing the M subunit, to produce as a precipitate the reaction product of said second antibody with said other antibody and said creatine kinase isoenzymes containing the M subunit and thereafter quantitatively measuring the B isoenzyme activity of the supernatant in said second portion; and c. determining the CK-MB activity in said sample from said measurements through the substraction of the measurement obtained in the second portion, from the measurement obtained in the first portion.
Claim 3
Dependent Claim
14 words
A process according to claim 1 wherein the biological fluid sample is blood serum.
Claim 4
Dependent Claim
43 words
A process according to claim 1 wherein the first antibody of step (a) and the antibody binding the creatine kinase isoenzyme containing the M subunit of step (b) are goat anti-creatine kinase-MM, and the second antibody of step (b) is donkey anti-goat IgG.
Claim 5
Dependent Claim
16 words
A process according to claim 1 wherein the second antibody is bound to a solid support.
Claim 6
Dependent Claim
12 words
A process according to claim 4 wherein the solid support is polyvinylidenefluoride.
Claim 7
Dependent Claim
19 words
A process according to claim 1 wherein the enzymatic activity of B isoenzyme is determined by a spectrophotometric assay.
Claim 8
Dependent Claim
17 words
A process according to claim 6 wherein the spectrophotometric assay comprises: an enzyme-co enzyme and substrate mixture.
References Cited (Backward Citations)
US3932221A
Cited
US4012285A
Cited
US3843443A
Cited
US4067775A
Cited
US4224406A
Cited
US4298592A
Cited
US4353982A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-06-06 | 1986-12-06 | 1987-06-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-06-06 | 1990-12-06 | 1991-06-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-06-06 | 1994-12-06 | 1995-06-07 | $7700.00 | Window Closed / Lapsed |